Exemestane is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Inc.. The primary component is Exemestane.
| Product ID | 0832-0595_1110149a-fd25-4717-a01d-7f8a8ace0c50 |
| NDC | 0832-0595 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Exemestane |
| Generic Name | Exemestane |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-07-27 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209208 |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | EXEMESTANE |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-07-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA209208 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-07-27 |
| Ingredient | Strength |
|---|---|
| EXEMESTANE | 25 mg/1 |
| SPL SET ID: | f8bd17b4-5289-45bb-8095-de89dc8d39ed |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0080 | Exemestane | Exemestane |
| 0378-5001 | Exemestane | exemestane |
| 0832-0595 | Exemestane | Exemestane |
| 44278-025 | Exemestane | EXEMESTANE |
| 47781-108 | Exemestane | Exemestane |
| 50090-5193 | Exemestane | Exemestane |
| 51991-005 | Exemestane | Exemestane |
| 59651-516 | Exemestane | Exemestane |
| 59762-2858 | EXEMESTANE | Exemestane |
| 63629-2056 | Exemestane | Exemestane |
| 65162-240 | Exemestane | Exemestane |
| 68382-383 | Exemestane | Exemestane |
| 69097-316 | EXEMESTANE | exemestane |
| 70771-1374 | Exemestane | Exemestane |
| 71921-190 | Exemestane | Exemestane |
| 0009-7663 | Aromasin | exemestane |